The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma
Purpose: The clinical impact of the platelet-to-lymphocyte ratio (PLR) on the prognosis of patients with metastatic renal cell carcinoma (mRCC) remains controversial. We investigated the associations between elevation of the PLR and disease prognosis in patients with synchronous mRCC. Materials and...
Main Authors: | Hyeong Dong Yuk, Minyong Kang, Eu Chang Hwang, Jae Young Park, Chang Wook Jeong, Cheryn Song, Seong Il Seo, Seok-Soo Byun, Cheol Kwak, Sung-Hoo Hong, Jinsoo Chung, Hakmin Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Urological Association
2020-09-01
|
Series: | Investigative and Clinical Urology |
Subjects: | |
Online Access: | https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-61-475.pdf |
Similar Items
-
The clinical impact of strict criteria for active surveillance of prostate cancer in Korean population: Results from a prospective cohort
by: Jungyo Suh, et al.
Published: (2021-07-01) -
Clinical outcomes of muscle invasive bladder Cancer according to the BASQ classification
by: Hyeong Dong Yuk, et al.
Published: (2019-09-01) -
Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting
by: Seung Il Jung, et al.
Published: (2020-01-01) -
Animal models of bone metastatic prostate cancer
by: Jong Hyun Tae, et al.
Published: (2023-05-01) -
Survival and clinical prognostic factors in metastatic non‐clear cell renal cell carcinoma treated with targeted therapy: A multi‐institutional, retrospective study using the Korean metastatic renal cell carcinoma registry
by: Jung Kwon Kim, et al.
Published: (2019-07-01)